| Jul 12 |
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
|
| Jul 8 |
Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
|
| Jul 5 |
Phio Pharmaceuticals terminates share purchase agreement with Triton Funds
|
| Jul 5 |
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
|
| Jul 2 |
Phio Pharmaceuticals Announces Reverse Stock Split
|
| Jun 18 |
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
|
| Jun 12 |
Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
|
| Jun 11 |
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying
|
| May 28 |
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
|
| May 23 |
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
|
